Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Korsana Biosciences, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | Other | n/a (No price was disclosed in the filing) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | Other | n/a (No price was disclosed in the filing) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | Other | n/a (No price was disclosed in the filing) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | Exercise | $454.7K | Unusual size | SEC | |
Apogee Therapeutics, Inc.Security delisted | Exercise | $541.2K | Unusual size | SEC | |
Apogee Therapeutics, Inc.Security delisted | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CRESCENT BIOPHARMA, INC.Listing unverified | BuyD (derivative) | $7.6M | SEC | ||
CRESCENT BIOPHARMA, INC.Listing unverified | Buy | $12.4M | conv 30 | SEC | |
Oruka Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Oruka Therapeutics, Inc.Listing on record | Sell | $300M | SEC | ||
Oruka Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Spyre Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Spyre Therapeutics, Inc.Listing on record | Sell | $399.7M | SEC | ||
Spyre Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Apogee Therapeutics, Inc.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Jade Biosciences, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CRESCENT BIOPHARMA, INC.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Oruka Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |